Opus Genetics, Inc. IRD
3.93 USD +0.23 (+6.22%)
At closeNov 3, 2026, 4:01 PM EST
3.90 -0.03 -0.76%
After hours · Nov 3, 4:01 PM ET
3.74 Day range 3.99
1.70 52-week range 7.07
- YTD
- +95.52%
- 1 year
- +83.64%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.50 +167.2% upside
Now 3.93
- Target (low)
- 8.00
- Target (mean)
- 10.50
- Target (high)
- 15.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 3
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.02667 | -0.28 – 0.58 | -0.21 | +112.7% | 11.10M | +556.7% | 3 |
| Next quarter | -0.29 | -0.29 – -0.29 | -0.29 | 0.0% | 2.00M | +16.9% | 1 |
| Current year | -0.74667 | -1.15 – 0.02 | -0.46 | -62.3% | 17.80M | -6.6% | 3 |
| Next year | -0.81667 | -1.03 – -0.32 | -0.74667 | -9.4% | 19.57M | +10.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 23, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 14, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 13, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |